Biotech · Private company
Daxor Corporation
Track this companyFree. Adds Daxor Corporation to your Dealase workspace and tells you when its record changes.
Clinical trials60 recruiting or active
Pipeline programs3From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline3
- BVA-100Acute Decompensated Heart FailureClinicalTrials.gov · fetched Nov 12, 2026
- BVA-100Heart FailureClinicalTrials.gov · fetched Nov 12, 2026
- BVA-200Heart FailureClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials6
- BVA-200 vs BVA-100 Validation StudyCOMPLETED · started May 23, 2023ClinicalTrials.gov NCT06227819 · fetched Nov 12, 2026
- Evaluation of Blood Volume Analysis- Guided Management of Decompensated Heart FailureNA · COMPLETED · started May 1, 2022ClinicalTrials.gov NCT04855097 · fetched Nov 12, 2026
- Monitoring Outpatient Blood VolumE in Heart FailureCOMPLETED · started Sep 16, 2021ClinicalTrials.gov NCT04660396 · fetched Nov 12, 2026
- Blood Volume Assessment in COVID-19 and Bacterial SepsisCOMPLETED · started Aug 1, 2020ClinicalTrials.gov NCT04517695 · fetched Nov 12, 2026
- Daxor - Blood Volume AnalysisNA · COMPLETED · started Jul 16, 2020ClinicalTrials.gov NCT04111185 · fetched Nov 12, 2026
- A Feasibility Study on Ultrafiltration and Blood Volume MeasurementsNA · TERMINATED · started Dec 19, 2019ClinicalTrials.gov NCT04241718 · fetched Nov 12, 2026